The praziquantel in preschoolers (PIP) trial: study protocol for a phase II PK/PD-driven randomised controlled trial of praziquantel in children under 4 years of age

BACKGROUND: Over 200 million individuals worldwide are infected with Schistosoma species, with over half of infections occurring in children. Many children experience first infections early in life and this impacts their growth and development; however praziquantel (PZQ), the drug used worldwide for...

Descripción completa

Detalles Bibliográficos
Autores principales: Webb, Emily L., Edielu, Andrew, Wu, Hannah W., Kabatereine, Narcis B., Tukahebwa, Edridah M., Mubangizi, Alfred, Adriko, Moses, Elliott, Alison M., Hope, William W., Mawa, Patrice A., Friedman, Jennifer F., Bustinduy, Amaya L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419815/
https://www.ncbi.nlm.nih.gov/pubmed/34488846
http://dx.doi.org/10.1186/s13063-021-05558-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419815/
https://www.ncbi.nlm.nih.gov/pubmed/34488846
http://dx.doi.org/10.1186/s13063-021-05558-1

Ejemplares similares